PORT for Health 2026

PORT for Health: Oncology 2026

Is a tumor an autonomous aggressor? For decades, we viewed cancer as an isolated cluster of mutated cells. Modern oncology is completely rewriting this playbook.

We are pleased to invite you to the upcoming conference organized by our Member Company, Łukasiewicz – PORT Polish Center for Technology Development, and the P4Health Center of Excellence.

The PORT for Health: Oncology 2026 conference returns to Wrocław this May, bringing together over 20 world-class international speakers. The event will challenge the traditional paradigm of cancer, exploring the disease as a dynamic, complex ecosystem where the nervous system, immune system, and cellular microenvironment engage in a continuous dialogue.

---

Key Highlights & Themes:

• The Thinking Tumor (Neurooncology): Keynote speaker Prof. Frank Winkler (University of Heidelberg, The Brain Prize 2025 laureate) will present groundbreaking research showing how glioblastoma cells literally integrate into the brain’s electrical circuits, opening doors to novel therapeutic strategies.
• Immuno-oncology & Microenvironment: Discover how the nervous system co-determines tumor environments and how cells within the tumor microenvironment can actively alter immune responses.
• Advanced Therapies & AI: Explore the future of oncology, from utilizing oncolytic viruses as vectors for long-term anti-tumor immunity to using AI models to design miniature proteins targeting previously “undruggable” molecular structures.

The conference bridges the gap between fundamental tumor biology and practical clinical applications, focusing on translating laboratory discoveries into medical technologies and personalized therapies.

---

Event Details:

• Date: May 28–29, 2026
• Location: Wrocław, Poland & ONLINE (Hybrid Format)
• Target Audience: Researchers, clinicians, and representatives from the biotechnology and pharmaceutical sectors.
• Organizer: Łukasiewicz – PORT & P4Health Center of Excellence

Join global experts in shaping the future of personalized medicine and oncology.

---